Net Loss Per Share (Details) - Schedule of No Potential Common Stock Equivalents (Parentheticals) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Potentially Dilutive Common Stock [Abstract]
Weighted average number of common shares outstanding, diluted	15,322	13,632
Net loss per share - diluted	$ (0.66)	$ (0.36)